
XOMA Corporation Financial Ratios 2025-2008 | XOMA
Brief overview of XOMA Corporation's valuation and returns
This overview follows the five latest available observations from 2009 through 2025.
Key multiples at the end of the period are P/E 10.42x (median 15.67x), EV/EBITDA 29.02x (median 10.85x), P/S 6.34x (median 6.49x). Current valuation broadly matches recent historical reference points; the difference from five-year medians is +0.1%.
At the current P/E, inverse earnings yield is 9.6%, a useful bridge between price and business earnings.
End-period return metrics are ROE 37.8%, ROA 11.6%, ROCE 13.6%. Returns on capital and assets point to efficient economics and a strong internal source of growth.
The cash conversion cycle lengthened from 2.3 days to 23.6 days, or 21.3 days. More cash is tied up in operations.
Valuation takeaway
XOMA Corporation's profile looks neutral, with price and fundamental efficiency broadly aligned.
Annual Financial Ratios XOMA Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
10.4 | -23.2 | -6.9 | -0.0 | 15.7 | 29.1 | -103.1 | -7.6 | 17.4 | -0.5 | -5.8 | -10.0 | -5.6 | -2.3 | -1.3 | -0.0 | 4.9 | - |
P/S |
6.3 | 11.2 | 59.2 | 0.0 | 6.5 | 13.2 | 11.1 | 19.2 | 4.8 | 4.6 | 2.1 | 20.3 | 19.5 | 4.9 | 0.8 | 0.1 | 0.0 | - |
EPS |
1.5 | -1.6 | -4.0 | -2.0 | 0.7 | 0.8 | -0.2 | -1.6 | 0.8 | -8.9 | -3.5 | -7.1 | -1.4 | -1.1 | -1.0 | -3.7 | 0.1 | - |
EV (Enterprise Value) |
416 M | 358 M | 274 M | -41.2 M | 179 M | 341 M | 199 M | 101 M | 250 M | 75.5 M | 130 M | 391 M | 730 M | 206 M | 58.6 M | 16 M | -21.2 M | -9.51 M |
EBITDA per Share |
1.19 | -3.4 | -3.57 | -1.52 K | 1.55 | 1.17 | -0.44 | -1.78 | 2.73 | -9.34 | -5.86 | -14.9 | -12.7 | -14.7 | -18.1 | -3.3 K | 1.8 K | - |
EV/EBITDA |
29.0 | -9.0 | -6.7 | 2.4 | 9.5 | 26.4 | -46.6 | -5.2 | 10.9 | -0.8 | -3.0 | -4.3 | -11.4 | -3.4 | -1.0 | -0.3 | -1.1 | - |
PEG |
-0.0 | 0.0 | 0.0 | 0.0 | -0.11 | 0.04 | -1.21 | 0.02 | 0.16 | 0.0 | -0.11 | -0.13 | 0.19 | 0.41 | -0.02 | - | - | - |
P/B |
3.2 | 3.9 | 3.2 | 0.0 | 1.7 | 4.5 | 4.6 | 5.4 | 44.0 | -0.5 | -51.5 | 123.4 | -173.8 | 7.8 | 2.9 | 0.1 | - | - |
P/CF |
115.1 | -23.3 | -15.5 | -0.0 | 10.9 | 43.5 | -10.4 | -3.7 | 95.0 | -0.8 | -3.8 | -4.9 | -14.7 | -3.9 | -1.4 | -0.0 | 0.4 | - |
ROE % |
37.78 | -22.33 | -46.02 | -13.79 | 11.14 | 15.39 | -4.51 | -71.03 | 252.26 | 113.39 | 892.42 | -1235.91 | 3111.56 | -331.04 | -218.13 | -291.45 | 3.14 | - |
ROA % |
11.63 | -6.25 | -17.43 | -12.18 | 9.48 | 10.61 | -2.07 | -20.92 | 32.48 | -186.67 | -27.52 | -42.73 | -92.04 | -67.25 | -41.96 | -92.60 | - | - |
ROCE % |
13.56 | -64.58 | -47.17 | -14.04 | 12.36 | 10.99 | -4.47 | -25.73 | 54.59 | 1488.43 | -69.84 | -153.79 | -55.05 | -62.99 | -59.54 | -284.45 | 73.95 | - |
Current Ratio |
1.6 | 1.6 | 1.6 | 8.6 | 6.7 | 7.2 | 6.8 | 8.4 | 6.0 | 0.8 | 3.1 | 2.3 | 4.3 | 4.0 | 3.0 | 1.5 | - | - |
DSO |
23.6 | 18.2 | 38.5 | 6.3 | 2.3 | 22.2 | 58.3 | 101.1 | 2.8 | 37.1 | 26.8 | 64.0 | 38.9 | 89.1 | 77.3 | 113.2 | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | 9870.3 | - | - | - | - |
Operating Cycle |
23.6 | 18.2 | 38.5 | 6.3 | 2.3 | - | - | - | - | - | - | - | - | 89.1 | - | 113.2 | - | - |
Cash Conversion Cycle |
23.6 | 18.2 | 38.5 | 6.3 | 2.3 | - | - | - | - | - | - | - | - | -9781.2 | - | 113.2 | - | - |
All numbers in USD currency
Quarterly Financial Ratios XOMA Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.18 | 0.74 | 0.46 | 0.06 | - | -1.59 | 0.88 | -0.86 | - | -0.6 | -0.59 | -0.98 | - | -0.48 | -0.53 | -0.32 | - | -0.51 | -0.31 | -0.7 | 1.4 | -0.1 | -0.33 | -0.49 | -0.49 | 0.21 | -0.47 | 0.22 | -0.35 | -0.55 | -0.23 | -0.46 | -0.16 | 2.06 | 0.02 | -2.37 | -2.89 | -2.08 | -2.52 | -1.4 | 4.27 | -0.08 | -4.04 | -3.74 | -0.07 | -0.13 | -0.11 | -0.04 | -0.55 | 0.34 | 0.21 | -0.3 | 0.03 | -0.39 | -0.24 | -0.69 | -0.34 | -0.2 | -0.27 | -0.22 |
EBITDA per Share |
0.03 | -0.04 | 0.44 | 0.54 | - | - | - | - | - | -0.48 | -0.5 | -868 | - | -382 | -417 | -182 | - | -0.3 | -0.27 | -0.57 | 2.13 | -0.24 | -0.29 | -0.57 | -0.41 | 0.33 | -0.54 | 0.22 | -0.39 | -0.63 | -0.36 | -0.62 | -0.24 | 3.72 | 0.2 | -1.56 | -2.86 | -1.91 | -2.92 | -2.3 | 4.83 | -0.19 | -0.18 | -0.19 | -0.17 | -0.18 | -0.17 | -0.22 | - | -0.17 | -0.15 | -0.13 | - | -0.19 | -0.16 | -0.3 | - | -0.09 | -173 | -0.16 |
ROE % |
36.27 | 4.85 | 8.86 | -14.27 | -17.06 | -22.26 | -0.55 | -29.11 | -18.67 | -21.88 | -20.14 | -16.86 | -8.30 | -12.27 | -10.98 | -16.55 | -14.92 | 11.31 | 14.04 | 11.87 | 15.39 | -20.66 | -12.19 | -17.36 | -4.51 | -10.72 | -42.31 | -43.42 | -71.03 | -77.78 | 401.90 | 417.19 | 252.26 | 312.07 | -116.71 | -89.52 | 113.39 | -1021.56 | -1027.30 | -30.44 | 892.42 | 1754.20 | 1268.78 | -144.09 | -1235.91 | 311.96 | 1519.61 | 2336.12 | 3111.56 | 1810.85 | 942.75 | 434.89 | -331.04 | -420.24 | -338.75 | -317.65 | -218.13 | -43.59 | -54.16 | -42.20 |
ROA % |
12.21 | 2.84 | 4.08 | -4.48 | -5.59 | -9.89 | -9.51 | -16.08 | -16.08 | -18.94 | -15.93 | -15.03 | -7.69 | -9.34 | -6.48 | -12.63 | -11.20 | 6.89 | 9.43 | 8.26 | 10.61 | -11.99 | -7.81 | -9.25 | -2.07 | -2.28 | -12.78 | -11.57 | -20.92 | -19.13 | 46.67 | 50.36 | 32.48 | -25.54 | -127.84 | -181.34 | -186.67 | -91.85 | -48.82 | -27.68 | -27.52 | -69.56 | -85.02 | -66.60 | -42.84 | -73.46 | -79.33 | -78.82 | -92.04 | -51.00 | -54.43 | -56.92 | -67.25 | -84.52 | -67.50 | -62.63 | -41.96 | -8.38 | -10.42 | -8.12 |
ROCE % |
11.33 | -12.29 | -23.38 | -38.24 | -45.25 | -50.71 | -31.98 | -28.26 | -19.75 | -23.11 | -21.18 | -17.24 | -8.36 | -11.36 | -10.63 | -14.97 | -13.49 | 14.13 | 14.02 | 13.00 | 14.37 | -22.35 | -12.67 | -19.73 | -8.83 | -17.95 | -52.78 | -57.99 | -89.74 | -106.26 | 417.15 | 455.73 | 294.35 | 366.07 | -103.48 | -87.97 | 130.39 | -1151.28 | -151.43 | 772.42 | 1720.40 | 2347.86 | 662.41 | -905.51 | -2640.59 | -1591.38 | -578.27 | 311.65 | 1069.12 | 993.88 | 499.06 | 79.03 | -204.99 | -251.08 | -228.25 | -212.85 | -145.95 | -46.09 | -52.42 | -47.44 |
Current Ratio |
1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.7 | - | 1.6 | 6.8 | 8.1 | 7.0 | 8.6 | 9.2 | - | 8.3 | 6.8 | 6.9 | 7.1 | 3.1 | 3.2 | 3.2 | 3.2 | 3.2 | 1.9 | 1.9 | 1.9 | 1.9 | 1.4 | 1.4 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | 1.1 | 0.4 | 0.4 | 0.4 | 0.4 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
DSO |
30.2 | 26.3 | 25.6 | 21.2 | - | 10.0 | 2.2 | 30.7 | - | 51.9 | 25.0 | 0.7 | - | 1.6 | 1.2 | 3.4 | - | 25.7 | 4.7 | 41.7 | 0.9 | 43.1 | 54.0 | 181.4 | 726.1 | 32.8 | 252.9 | 23.7 | 79.5 | 149.5 | 59.4 | 183.8 | 6.8 | 1.0 | 3.3 | 169.0 | 98.6 | 81.3 | 116.6 | 53.4 | 7.7 | 179.0 | 146.2 | 127.0 | 69.5 | 58.8 | 50.5 | 94.9 | 27.5 | 54.7 | 48.2 | 58.1 | 101.8 | 103.8 | 81.2 | 95.2 | 114.3 | 69.3 | 68.1 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 41783.8 | 13373.1 | - | 12602.3 | 4356.3 | - | - | - | - | - |
Operating Cycle |
- | 26.3 | 25.6 | 21.2 | - | 10.0 | - | - | - | 51.9 | 25.0 | 0.7 | - | 1.6 | 1.2 | 3.4 | - | 25.7 | 4.7 | 41.7 | 0.9 | 43.1 | 54.0 | 181.4 | 726.1 | 32.8 | 252.9 | 23.7 | 79.5 | 149.5 | 59.4 | 183.8 | 6.8 | 1.0 | 3.3 | 169.0 | 98.6 | 81.3 | 116.6 | 53.4 | 7.7 | 179.0 | 146.2 | 127.0 | 69.5 | 58.8 | 50.5 | 94.9 | 27.5 | 54.7 | 48.2 | 58.1 | 101.8 | 103.8 | 81.2 | 95.2 | 114.3 | 69.3 | 68.1 | - |
Cash Conversion Cycle |
- | 26.3 | 25.6 | 21.2 | - | 10.0 | - | - | - | 51.9 | 25.0 | 0.7 | - | 1.6 | 1.2 | 3.4 | - | 25.7 | 4.7 | 41.7 | 0.9 | 43.1 | 54.0 | 181.4 | 726.1 | 32.8 | 252.9 | 23.7 | 79.5 | 149.5 | 59.4 | 183.8 | 6.8 | 1.0 | 3.3 | 169.0 | 98.6 | 81.3 | 116.6 | 53.4 | 7.7 | 179.0 | 146.2 | 127.0 | 69.5 | 58.8 | 50.5 | 94.9 | 27.5 | 54.7 | -41735.6 | -13315.0 | 101.8 | -12498.5 | -4275.2 | 95.2 | 114.3 | 69.3 | 68.1 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company XOMA Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.